ajkdblog.org
Bexagliflozin in Patients With Type 2 Diabetes Mellitus and Stage 3 CKD
There has been significant interest in SGLT2 inhibitors (SGLT2i) as novel oral anti-hyperglycemic agents that have been recently approved for the treatment of type 2 diabetes mellitus (T2DM). Studi…